CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
357.6
0.14%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Thu: 08:00 - 16:20

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 3.8
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.015668 %
Charges from full value of position ($-2.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.015668%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.006555 %
Charges from full value of position ($-1.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.006555%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5%
Stock exchange Switzerland
Commission on trade 0%

*Information provided by Capital.com

Ypsomed Holding AG ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 358.1
Open* 356.6
1-Year Change* 95.61%
Day's Range* 350.1 - 359.1
52 wk Range 177.80-309.00
Average Volume (10 days) 8,360.00
Average Volume (3 months) 200.30K
Market Cap 4.05B
P/E Ratio 55.91
Shares Outstanding 13.65M
Revenue 508.61M
EPS 5.31
Dividend (Yield %) 0.43771
Beta 1.26
Next Earnings Date May 22, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 357.6 1.0 0.28% 356.6 359.1 350.1
Mar 27, 2024 358.1 -4.4 -1.21% 362.5 367.0 354.6
Mar 26, 2024 358.6 1.0 0.28% 357.6 361.6 352.1
Mar 25, 2024 356.6 -2.0 -0.56% 358.6 360.6 348.1
Mar 22, 2024 359.0 5.9 1.67% 353.1 362.1 353.1
Mar 21, 2024 359.1 15.0 4.36% 344.1 359.6 340.6
Mar 20, 2024 350.1 3.0 0.86% 347.1 356.6 337.6
Mar 19, 2024 345.6 -5.0 -1.43% 350.6 350.6 336.6
Mar 18, 2024 350.6 0.5 0.14% 350.1 354.6 344.1
Mar 15, 2024 355.1 -4.0 -1.11% 359.1 359.6 347.1
Mar 14, 2024 359.6 14.5 4.20% 345.1 361.6 335.6
Mar 13, 2024 348.6 -8.0 -2.24% 356.6 358.1 347.1
Mar 12, 2024 353.1 -9.4 -2.59% 362.5 362.5 351.6
Mar 11, 2024 362.0 -8.0 -2.16% 370.0 375.0 356.6
Mar 8, 2024 368.0 2.0 0.55% 366.0 371.5 361.0
Mar 7, 2024 365.5 6.9 1.92% 358.6 367.0 353.6
Mar 6, 2024 360.1 1.5 0.42% 358.6 361.1 358.1
Mar 5, 2024 360.6 5.5 1.55% 355.1 362.6 354.6
Mar 4, 2024 360.1 -4.9 -1.34% 365.0 366.0 354.1
Mar 1, 2024 365.5 3.5 0.97% 362.0 365.5 357.1

Ypsomed Holding AG Events

Time (UTC) Country Event
Wednesday, May 22, 2024

Time (UTC)

10:59

Country

CH

Event

Full Year 2024 Ypsomed Holding AG Earnings Call
Full Year 2024 Ypsomed Holding AG Earnings Call

Forecast

-

Previous

-

Time (UTC)

10:59

Country

CH

Event

Full Year 2024 Ypsomed Holding AG Earnings Release
Full Year 2024 Ypsomed Holding AG Earnings Release

Forecast

-

Previous

-
Wednesday, June 26, 2024

Time (UTC)

10:59

Country

CH

Event

Ypsomed Holding AG Annual Shareholders Meeting
Ypsomed Holding AG Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 497.46 464.841 403.656 394.264 453.765
Revenue 497.46 464.841 403.656 394.264 453.765
Cost of Revenue, Total 356.868 351.024 308.828 303.29 297.351
Gross Profit 140.592 113.817 94.828 90.974 156.414
Total Operating Expense 436.866 436.262 394.388 384.096 381.738
Selling/General/Admin. Expenses, Total 103.293 89.42 94.059 89.156 90.086
Unusual Expense (Income) -17.394 -2.8 -8.181 1.317
Other Operating Expenses, Total -5.901 -4.182 -0.699 -0.169 -7.016
Operating Income 60.594 28.579 9.268 10.168 72.027
Interest Income (Expense), Net Non-Operating -3.736 -2.904 -3.104 -2.432 -2.608
Other, Net -0.221 -0.135 -0.051 0.118 0.461
Net Income Before Taxes 56.637 25.54 6.113 7.854 69.88
Net Income After Taxes 51.275 23.105 5.811 11.734 60.136
Net Income Before Extra. Items 51.275 23.105 5.811 11.734 60.136
Net Income 51.275 23.105 5.811 11.734 60.136
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items 51.275 23.105 5.811 11.734 60.136
Income Available to Common Incl. Extra. Items 51.275 23.105 5.811 11.734 60.136
Diluted Net Income 51.275 23.105 5.811 11.734 60.136
Diluted Weighted Average Shares 13.4187 12.645 12.6122 12.603 12.603
Diluted EPS Excluding Extraordinary Items 3.82117 1.8272 0.46074 0.93105 4.77158
Dividends per Share - Common Stock Primary Issue 1.3 0.6 1.16 0.2 0.55
Diluted Normalized EPS 2.64764 1.8272 0.92805 0.50911 4.86151
Interest Expense (Income) - Net Operating -5
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total revenue 253.216 244.244 242.253 222.588 204.323
Revenue 253.216 244.244 242.253 222.588 204.323
Cost of Revenue, Total 178.072 178.796 180.778 170.246 156.813
Gross Profit 75.144 65.448 61.475 52.342 47.51
Total Operating Expense 212.068 224.798 224.162 212.1 203.397
Selling/General/Admin. Expenses, Total 54.201 49.092 45.555 43.865 53.134
Unusual Expense (Income) 0
Other Operating Expenses, Total -20.205 -3.09 -2.171 -2.011 -6.55
Operating Income 41.148 19.446 18.091 10.488 0.926
Interest Income (Expense), Net Non-Operating -1.117 -2.619 -0.998 -1.906 -2.286
Other, Net -0.133 -0.088 -0.12 -0.015 -0.157
Net Income Before Taxes 39.898 16.739 16.973 8.567 -1.517
Net Income After Taxes 35.836 15.439 15.981 7.124 -0.717
Net Income Before Extra. Items 35.836 15.439 15.981 7.124 -0.717
Net Income 35.836 15.439 15.981 7.124 -0.717
Income Available to Common Excl. Extra. Items 35.836 15.439 15.981 7.124 -0.717
Income Available to Common Incl. Extra. Items 35.836 15.439 15.981 7.124 -0.717
Diluted Net Income 35.836 15.439 15.981 7.124 -0.717
Diluted Weighted Average Shares 13.6162 13.2212 12.6471 12.643 12.6214
Diluted EPS Excluding Extraordinary Items 2.63187 1.16775 1.26361 0.56348 -0.05681
Dividends per Share - Common Stock Primary Issue 1.3 0 0.6 0 1.16
Diluted Normalized EPS 2.63187 1.16775 1.26361 0.56348 -0.05681
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 208.327 193.584 185.141 189.89 178.789
Cash and Short Term Investments 25.224 17.038 22.411 22.334 12.083
Cash 25.225 17.038 19.319 13.394 12.083
Total Receivables, Net 93.402 87.15 72.73 76.35 89.848
Accounts Receivable - Trade, Net 93.336 86.986 72.663 76.29 89.695
Total Inventory 57.704 68.299 63.357 56.286 52.412
Prepaid Expenses 15.053 10.672 12.948 14.672 11.308
Other Current Assets, Total 16.944 10.425 13.695 20.248 13.138
Total Assets 861.879 756.91 717.683 678.24 587.748
Property/Plant/Equipment, Total - Net 379.587 327.945 326.197 300.712 256.142
Property/Plant/Equipment, Total - Gross 733.186 647.933 624.652 572.488 500.597
Accumulated Depreciation, Total -353.599 -319.989 -298.455 -271.776 -244.456
Intangibles, Net 231.738 190.779 160.728 102.516 81.419
Long Term Investments 10.729 10.847 10.85 8.57 21.225
Other Long Term Assets, Total 31.498 33.755 34.767 33.068 2.812
Total Current Liabilities 258.988 237.336 272.377 276.003 187.883
Accounts Payable 19.62 17.386 34.553 24.044 19.348
Accrued Expenses 44.284 36.789 29.283 26.678 31.757
Notes Payable/Short Term Debt 157 157 182.5 182.999 112
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total 38.084 26.161 26.041 42.282 24.778
Total Liabilities 299.546 364.37 322.298 300.581 208.944
Total Long Term Debt 0 110 32.5 10 10
Long Term Debt 0 110 32.5 10 10
Deferred Income Tax 2.51 2.783 2.539 2.168 2.9
Other Liabilities, Total 38.048 14.251 14.882 12.41 8.161
Total Equity 562.333 392.54 395.385 377.659 378.804
Common Stock 193.144 178.994 178.994 178.994 178.994
Retained Earnings (Accumulated Deficit) 708.878 559.72 551.068 547.28 539.871
Treasury Stock - Common -0.167 0 -0.956 -6.595 -6.595
Other Equity, Total -339.522 -346.174 -333.721 -342.02 -333.466
Total Liabilities & Shareholders’ Equity 861.879 756.91 717.683 678.24 587.748
Total Common Shares Outstanding 13.6487 12.6497 12.643 12.603 12.603
Note Receivable - Long Term 0 43.484 47.361
Short Term Investments 0 3.091 8.94
Cash & Equivalents -0.001 0.001
Sep 2023 Mar 2023 Sep 2022 Mar 2022 Sep 2021
Total Current Assets 249.253 208.327 192.131 193.584 185.303
Cash and Short Term Investments 36.379 25.224 17.15 17.038 30.047
Cash & Equivalents 36.379 25.224 17.15 17.038 27.625
Short Term Investments 0 2.422
Total Receivables, Net 95.754 93.402 81.323 87.15 75.657
Accounts Receivable - Trade, Net 95.691 93.336 81.264 86.986 75.59
Total Inventory 69.506 57.704 70.949 68.299 62.091
Prepaid Expenses 15.833 15.053 13.005 10.672 9.721
Other Current Assets, Total 31.781 16.944 9.704 10.425 7.787
Total Assets 936.683 861.879 790.843 756.91 734.594
Property/Plant/Equipment, Total - Net 397.764 387.677 362.447 336.15 337.179
Intangibles, Net 256.894 231.738 200.747 190.779 174.734
Long Term Investments 2.638 2.639 2.636 2.642 2.648
Note Receivable - Long Term
Other Long Term Assets, Total 30.134 31.498 32.882 33.755 34.73
Total Current Liabilities 322.278 258.988 265.15 237.336 277.833
Accounts Payable 24.599 19.62 20.701 17.386 19.762
Accrued Expenses 45.637 44.284 47.303 36.789 32.788
Notes Payable/Short Term Debt 203 157 144 157 204.5
Other Current Liabilities, Total 49.042 38.084 28.143 26.161 20.783
Total Liabilities 362.991 299.546 281.803 364.37 350.013
Total Long Term Debt 0 0 0 110 55
Long Term Debt 0 0 110 55
Deferred Income Tax 2.079 2.51 2.631 2.783 2.602
Other Liabilities, Total 38.634 38.048 14.022 14.251 14.578
Total Equity 573.692 562.333 509.04 392.54 384.581
Common Stock 193.144 193.144 193.144 178.994 178.994
Retained Earnings (Accumulated Deficit) 727.79 708.878 672.973 559.72 543.525
Treasury Stock - Common -0.167 -0.167 0 -0.956
Other Equity, Total -347.075 -339.522 -357.077 -346.174 -336.982
Total Liabilities & Shareholders’ Equity 936.683 861.879 790.843 756.91 734.594
Total Common Shares Outstanding 13.6487 13.6487 13.6497 12.6497 12.643
Current Port. of LT Debt/Capital Leases 25.003
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line 51.275 23.105 5.811 11.452 60.136
Cash From Operating Activities 129.531 85.706 85.828 49.088 59.859
Cash From Operating Activities 78.56 68.081 56.025 52.799 44.888
Non-Cash Items -11.087 1.942 36.387 -29.115 -44.691
Changes in Working Capital 10.783 -7.422 -12.395 13.952 -0.474
Cash From Investing Activities -122.019 -125.7 -106.914 -115.834 -128.39
Capital Expenditures -169.173 -127.43 -126.581 -118.731 -129.053
Other Investing Cash Flow Items, Total 47.154 1.73 19.667 2.897 0.663
Cash From Financing Activities 1.265 38.125 26.669 68.661 49.089
Total Cash Dividends Paid -8.19 -14.667 -2.521 -6.932 -17.644
Issuance (Retirement) of Stock, Net 34.458 0.791 6.136 0 -0.005
Issuance (Retirement) of Debt, Net -25.003 52 22.001 71.017 63
Foreign Exchange Effects -0.591 -0.412 0.342 -0.604 -0.587
Net Change in Cash 8.186 -2.281 5.925 1.311 -20.029
Financing Cash Flow Items 0.001 1.053 4.576 3.738
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Net income/Starting Line 51.275 15.439 23.105 7.124 5.811
Cash From Operating Activities 129.531 69.742 85.706 47.988 85.828
Cash From Operating Activities 78.56 37.438 68.081 31.94 56.025
Non-Cash Items -11.087 1.096 1.942 0.64 36.387
Changes in Working Capital 10.783 15.769 -7.422 8.284 -12.395
Cash From Investing Activities -122.019 -83.162 -125.7 -69.375 -106.914
Capital Expenditures -169.173 -83.363 -127.43 -68.497 -126.581
Other Investing Cash Flow Items, Total 47.154 0.201 1.73 -0.878 19.667
Cash From Financing Activities 1.265 13.964 38.125 29.834 26.669
Financing Cash Flow Items 0.001 1.053
Total Cash Dividends Paid -8.19 -8.19 -14.667 -14.666 -2.521
Issuance (Retirement) of Stock, Net 34.458 35.154 0.791 6.136
Issuance (Retirement) of Debt, Net -25.003 -13 52 44.5 22.001
Foreign Exchange Effects -0.591 -0.432 -0.412 -0.142 0.342
Net Change in Cash 8.186 0.112 -2.281 8.305 5.925

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Ypsomed Company profile

About Ypsomed Holding AG

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.

Financial summary

BRIEF: For the six months ended 30 September 2021, YpsomedHolding AG revenues increased 12% to SF222.6M. Net incomeincreased 7% to SF7.1M. Revenues reflect Diabetes Caresegment increase of 13% to SF95.2M, Delivery Systemssegment increase of 9% to SF118.3M. Net income waspartially offset by Marketing and sales expenses increaseof 7% to SF32.7M (expense), Gains from sale of securitiesdecrease of 98% to SF49K (income).

Equity composition

09/2006, Capital repayment of CHF 1.25 and nominal valuechanged from CHF 11.6. 08/2005, Capital repayment of CHF0.9 & Nominal value changed from CHF 12.5. 06/2009, RightsIssue, 1 new share for every 8 shares held. (Factor: 1.0).07/2009, Nominal value changed from EUR 9.75.

Industry: Medical Equipment, Supplies & Distribution (NEC)

Brunnmattstrasse 6
BURGDORF
BERN 3401
CH

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.63 Price
-1.420% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,543.77 Price
-0.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

69,988.60 Price
-1.120% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading